HHS Announces New Partnership Between the National Institutes of Health and the Food and Drug Administration

What:

To announce a new collaboration between the National Institutes of Health and the U.S. Food and Drug Administration on regulatory and translational science.

Who:

Speakers include HHS Secretary Kathleen Sebelius, NIH Director Francis S. Collins, M.D., Ph.D., and FDA Commissioner Margaret Hamburg, M.D.

When:

Wednesday, February 24, 2010, 10 a.m. EST

Where:

Lipsett Amphitheater, Building 10, National Institutes of Health, Bethesda, Maryland.

More Information:

This event will be videocast and archived at: http://videocast.nih.gov/.

Visitor information, including directions to NIH and information about campus access and security is available online at http://www.nih.gov/about/vistor/index.htm.

Sign language interpreters will be provided if requested. For other reasonable accommodations, please contact Calvin Jackson, NIH Office of Communications and Public Liaison at 301-594-8750 or by e-mail at cj8e@nih.gov.

The Office of the Director, the central office at NIH, is responsible for setting policy for NIH, which includes 27 Institutes and Centers. This involves planning, managing, and coordinating the programs and activities of all NIH components. The Office of the Director also includes program offices which are responsible for stimulating specific areas of research throughout NIH. Additional information is available at http://www.nih.gov/icd/od.

The National Institutes of Health (NIH) — The Nation’s Medical Research Agency — includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. It is the primary federal agency for conducting and supporting basic, clinical and translational medical research, and it investigates the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov.